Tag: Human Longevity (HLI)

Why Illumina Might Be Offering a Lucrative Investment Opportunity

Why Illumina Might Be Offering a Lucrative Investment Opportunity

Illumina Showing 6% revenue increase over the same quarter last year, Q1 2016, was not enough as Illumina (ILMN) missed analysts’ expectations and its own projections regarding its revenues. Prior to the announcement of its Q1 results, the giant gene sequencing firm offered investors a comprehensive explanation of the origin of the miss and the actions it has already begun to take to avoid future misses. Illumina pinpointed …
Human Longevity Firm Aims at Bringing the Missing Full Picture of Human Health

Human Longevity Firm Aims at Bringing the Missing Full Picture of Human Health

Years ago, a friend who is a highly regarded Immunologist lectured us during one of our visits to his home city Milano in Italy about the important role well written press releases play in highlighting the prominence of unknown, yet, capable biotech firms. “If not for its announced news, millions of interested people around the world, including myself, wouldn’t have heard on time about Genentech …